- Home
- Publications
- Publication Search
- Publication Details
Title
NAFLD
: Reporting Histologic Findings in Clinical Practice
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 73, Issue 5, Pages 2028-2038
Publisher
Wiley
Online
2020-10-28
DOI
10.1002/hep.31599
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
- (2020) Stefano Romeo et al. Cell Metabolism
- The economic cost and health burden of non-alcoholic steatohepatitis in the EU5 countries
- (2020) P. Newsome et al. DIGESTIVE AND LIVER DISEASE
- Therapeutic landscape for NAFLD in 2020
- (2020) Brent A. Neuschwander-Tetri GASTROENTEROLOGY
- The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver Disease
- (2020) F. Anthony Romero et al. JOURNAL OF MEDICINAL CHEMISTRY
- Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations from the Multi-stakeholder Liver Forum
- (2020) Mazen Noureddin et al. GASTROENTEROLOGY
- Non-Invasive Assessment of Liver Disease in Patients with NAFLD
- (2019) Laurent Castera et al. GASTROENTEROLOGY
- Predictors of bleeding complications following percutaneous image-guided liver biopsy: a scoping review
- (2019) Mehran Midia et al. Diagnostic and Interventional Radiology
- Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations from the Liver Forum
- (2019) Amanda Cheung et al. HEPATOLOGY
- Past, present and future perspectives in nonalcoholic fatty liver disease
- (2019) Arun J. Sanyal Nature Reviews Gastroenterology & Hepatology
- Report on the AASLD/EASL joint workshop on clinical trial endpoints in NAFLD
- (2019) Mary E. Rinella et al. JOURNAL OF HEPATOLOGY
- Economic and Clinical Burden of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes in the United States
- (2019) Zobair M. Younossi et al. DIABETES CARE
- In Children With Nonalcoholic Fatty Liver Disease, Zone 1 Steatosis Is Associated With Advanced Fibrosis
- (2018) Jonathan A. Africa et al. Clinical Gastroenterology and Hepatology
- Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis
- (2018) Giovanni Musso et al. GASTROENTEROLOGY
- Magnetic Resonance Imaging Proton Density Fat Fraction Associates With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2018) Veeral Ajmera et al. GASTROENTEROLOGY
- Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science
- (2018) Mohammad Shadab Siddiqui et al. HEPATOLOGY
- Lipotoxicity and the gut-liver axis in NASH pathogenesis
- (2018) Fabio Marra et al. JOURNAL OF HEPATOLOGY
- Pharmacotherapy for NASH: Current and emerging
- (2018) Monica A. Konerman et al. JOURNAL OF HEPATOLOGY
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Improvements in Histologic Features and Diagnosis associated with Improvement in Fibrosis in NASH : Results from the NASH Clinical Research Network Treatment Trials
- (2018) Elizabeth M Brunt et al. HEPATOLOGY
- Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis
- (2017) Parambir S. Dulai et al. HEPATOLOGY
- NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children
- (2017) Miriam B. Vos et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
- (2016) Timothy Hardy et al. Annual Review of Pathology-Mechanisms of Disease
- Pathogenesis of Nonalcoholic Steatohepatitis
- (2016) Mariana Verdelho Machado et al. GASTROENTEROLOGY
- The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis
- (2016) Petra Hirsova et al. JOURNAL OF LIPID RESEARCH
- Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease
- (2016) Manoela Mota et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies
- (2016) Giovanni Musso et al. NATURE REVIEWS DRUG DISCOVERY
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
- (2015) Mattias Ekstedt et al. HEPATOLOGY
- Practice patterns in NAFLD and NASH: real life differs from published guidelines
- (2015) Mary E. Rinella et al. Therapeutic Advances in Gastroenterology
- A Histologic Scoring System for Prognosis of Patients With Alcoholic Hepatitis
- (2014) José Altamirano et al. GASTROENTEROLOGY
- Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease
- (2014) Pierre Bedossa et al. HEPATOLOGY
- Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
- (2012) Kenneth Cusi GASTROENTEROLOGY
- Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients
- (2012) Pierre Bedossa et al. HEPATOLOGY
- Nonalcoholic Fatty Liver Disease: Pathologic Patterns and Biopsy Evaluation in Clinical Research
- (2012) David Kleiner et al. SEMINARS IN LIVER DISEASE
- Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease
- (2011) Cynthia D. Guy et al. HEPATOLOGY
- Costaining for keratins 8/18 plus ubiquitin improves detection of hepatocyte injury in nonalcoholic fatty liver disease
- (2011) Cynthia D. Guy et al. HUMAN PATHOLOGY
- Lipotoxicity in NASH
- (2011) Michael Fuchs et al. JOURNAL OF HEPATOLOGY
- Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression
- (2011) Mattias Ekstedt et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites
- (2010) Brent A. Neuschwander-Tetri HEPATOLOGY
- Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings
- (2010) Elizabeth M. Brunt et al. HEPATOLOGY
- Histopathology of nonalcoholic fatty liver disease
- (2010) Elizabeth M Brunt WORLD JOURNAL OF GASTROENTEROLOGY
- Ballooned hepatocytes in steatohepatitis: The value of keratin immunohistochemistry for diagnosis
- (2008) Carolin Lackner et al. JOURNAL OF HEPATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started